Senators Call for Investigation of Health Insurers ’ Role in Driving Up Drug Costs
A pair of U.S. senators called on the federal government to investigate health insurers that are paying high prices for generic drugs for serious diseases like cancer and multiple sclerosis. Sen. Elizabeth Warren (D., Mass.) and Sen. Mike Braun (R., Ind.) sent a letter on Wednesday to the U.S.…#elizabethwarren #mass #mikebraun #ind (Source: Reuters: Health)
Source: Reuters: Health - November 22, 2023 Category: Consumer Health News Source Type: news

How Viral Infections Cause Long-Term Health Problems
In a few patients, the immune system becomes misdirected, attacking the body instead of the virus. (Source: NYT Health)
Source: NYT Health - November 22, 2023 Category: Consumer Health News Authors: Apoorva Mandavilli Tags: your-feed-science Coronavirus (2019-nCoV) Multiple Sclerosis Autoimmune Diseases Immune System Long Covid Chronic Fatigue Syndrome Antibodies Mononucleosis Rheumatoid Arthritis Bacteria Lupus Erythematosus Source Type: news

Developing a Consensus on Smoldering MS
(MedPage Today) -- Fifteen multiple sclerosis (MS) experts from eight countries across Europe, U.S., and Canada have been convening to develop consensus-driven statements on smoldering MS across multiple domains. In this video, Antonio Scalfari... (Source: MedPage Today Neurology)
Source: MedPage Today Neurology - November 21, 2023 Category: Neurology Source Type: news

High NfL Levels Predict Greater MS Disability Within 2 Years
(MedPage Today) -- Multiple sclerosis patients whose blood tests revealed elevated levels of neurofilament light chain (NfL), a biomarker of axonal damage, had worsening disability 1 to 2 years later, according to a study presented at the joint... (Source: MedPage Today Neurology)
Source: MedPage Today Neurology - November 20, 2023 Category: Neurology Source Type: news

A Novel Mechanism of Action in Treating Relapsing MS
(MedPage Today) -- MedPage Today brought together three expert leaders for a virtual roundtable discussion on the joint meeting of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) and the Americas Committee for... (Source: MedPage Today Neurology)
Source: MedPage Today Neurology - November 17, 2023 Category: Neurology Source Type: news

Higher Neurofilament Light Chain Levels Seen Before MS Disability Worsening
THURSDAY, Nov. 16, 2023 -- Pronounced neuroaxonal damage precedes disability worsening events with or without preceding clinical relapses in people with multiple sclerosis (MS), according to a study published online Nov. 6 in JAMA... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 16, 2023 Category: Pharmaceuticals Source Type: news

Blood Test for MS Activity Gets FDA Breakthrough Designation Blood Test for MS Activity Gets FDA Breakthrough Designation
Roche ' s Elecsys NfL test is intended to be used as an aid in detection of disease activity in adults with relapsing-remitting multiple sclerosis or secondary progressive multiple sclerosis.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - November 15, 2023 Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news

New Data on CD40 Ligand Inhibitor for Relapsing MS
(MedPage Today) -- Treatment with the investigational CD40 ligand inhibitor frexalimab significantly reduced new MRI lesions in relapsing multiple sclerosis (MS) by week 24, according to data presented at the joint meeting of the European Committee... (Source: MedPage Today Neurology)
Source: MedPage Today Neurology - November 14, 2023 Category: Neurology Source Type: news

Low-fat Diets Battle Fatigue for Folks With MS
TUESDAY, Nov. 14, 2023 — Researchers have found a remedy for the debilitating fatigue faced by many patients with multiple sclerosis (MS): A low-fat diet. " The results reinforced what we had seen before, " said study leader Dr. Vijayshree Yadav,... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - November 14, 2023 Category: General Medicine Source Type: news

Should MS Patients Stop Treatment as They Age?
(MedPage Today) -- Stopping multiple sclerosis (MS) treatment as patients age can be a difficult decision, but there are considerations that may help with that process. In this exclusive video, Enrique Alvarez, MD, PhD, from the University of... (Source: MedPage Today Neurology)
Source: MedPage Today Neurology - November 13, 2023 Category: Neurology Source Type: news

Blood Test Might Predict Worsening of MS
KEY TAKEAWAYS:The progression of multiple sclerosis is particularly difficult to predict, varying widely between patientsA new blood test uses a biomarker of nerve cell damage to accurately predict progression over the next two yearsIf the test... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - November 13, 2023 Category: General Medicine Source Type: news

Targeting Chronic Inflammation in Progressive MS
(MedPage Today) -- MedPage Today brought together three expert leaders for a virtual roundtable discussion on the joint meeting of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) and the American Committee for... (Source: MedPage Today Neurology)
Source: MedPage Today Neurology - November 11, 2023 Category: Neurology Source Type: news

Roche ’s Elecsys NfL test, an important aid for those living with Multiple Sclerosis, is granted FDA Breakthrough Device Designation
Roche Elecsys NfL aids in detection of disease activity in adults with Multiple Sclerosis supporting better disease management decisionsElecsys NfL offers a minimally invasive testing option that can provide rapid answers to patients and caregiversNfL has the potential to provide patient insights for other neurological conditions such as Alzheimer ’s and Huntington’s diseasesBasel, 9 November 2023 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that its Elecsys ® Neurofilament Light Chain (NfL) test for Multiple Sclerosis (MS) received Breakthrough Device Designation from the U.S. Food and Drug Administration (FD...
Source: Roche Investor Update - November 9, 2023 Category: Pharmaceuticals Source Type: news

Roche ’s Elecsys NfL test, an important aid for those living with Multiple Sclerosis, is granted FDA Breakthrough Device Designation
Roche Elecsys NfL aids in detection of disease activity in adults with Multiple Sclerosis supporting better disease management decisionsElecsys NfL offers a minimally invasive testing option that can provide rapid answers to patients and caregiversNfL has the potential to provide patient insights for other neurological conditions such as Alzheimer ’s and Huntington’s diseasesBasel, 9 November 2023 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that its Elecsys ® Neurofilament Light Chain (NfL) test for Multiple Sclerosis (MS) received Breakthrough Device Designation from the U.S. Food and Drug Administration (FD...
Source: Roche Media News - November 9, 2023 Category: Pharmaceuticals Source Type: news

Caregiving is Caring for Yourself and Others
National Family Caregivers Month Celebrated every November, National Family Caregivers Month (NFCM) is a time to recognize and honor family caregivers across the country. It offers an opportunity to raise awareness of caregiving issues, educate communities, and increase support for caregivers. Who is a caregiver? Have you provided care for a child or an elderly parent, or offered respite for a friend or neighbor?  You are not alone. In the United States, approximately 43.5 million caregivers have provided unpaid care, or informal caregiving, to an adult or child in the last 12 months. A caregiver is anyone who ...
Source: The Cornflower - November 8, 2023 Category: Databases & Libraries Authors: Darlene Kaskie Tags: Blog Source Type: news